Side-by-side comparison of AI visibility scores, market position, and capabilities
1B+ monthly queries; 240M website visits/month; AI search category leader. $9B valuation; Perplexity Pro with GPT-4o and Claude 3.7 access. Sonar API for AI-native search in agentic applications. 15M+ registered users.
Perplexity AI is an AI-powered answer engine that provides direct, sourced responses to user queries by searching the web in real time and synthesizing information through large language models. Founded in 2022 and headquartered in San Francisco, Perplexity was created by Aravind Srinivas (formerly OpenAI), Denis Yarats, Johnny Ho, and Andy Konwinski with the vision of replacing the traditional search engine's link-based results with direct, cited answers that users can trust and verify.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.